Purchase Order VA26314P1353

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed-price purchase order to Medstar Health Research Institute Inc., doing business as Medstar Research Institute, to conduct a study on the natural history of coronavirus disease 2019 (COVID-19) in hospitalized patients at the Washington Hospital Center. The contract has a potential value of $112,465.60 and a completion date of October 31, 2022. Medstar Health Research Institute is a...

The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $1.74 million research grant by a civilian federal agency on April 22, 2019, with a completion date of May 31, 2031. This grant funds a comprehensive study examining the physiological effects of sleep on cognitive performance, neurological function, and immune response during long-duration spaceflight missions. The research employs an integrated approach combining assessments of sleep...

NASA awarded a $940,352 grant to Massachusetts General Hospital (MGH), the research division of The General Hospital Corporation, on April 1, 2020, to support research on Spaceflight Associated Neuro-ocular Syndrome (SANS), a significant medical concern for long-duration spaceflight missions. Under this non-set-aside grant with a completion deadline of March 31, 2026, MGH will develop and provide a comprehensive toolkit for detailed neurophysiological and fluid shift assessment and monitoring to...

The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded a $115,319.00 firm fixed-price purchase order to Medstar Health Research Institute Inc. (doing business as Medstar Research Institute) for technical development of cardiovascular MRI research coordination services. The award does not have a set-aside designation. Medstar Research Institute is a subsidiary of the non-profit healthcare provider Medstar...

This firm-fixed price federal contract award of $100,000.00 was issued by the National Institutes of Health (NIH) Clinical Center to the Medstar Health Research Institute Inc. (Medstar Research Institute), a non-profit organization that provides clinical research and healthcare services to federal agencies. The contract is for a SARS-CoV-2 study and does not have a set-aside designation. Medstar Research Institute is a subsidiary of the larger non-profit healthcare provider Medstar Health,...

The National Institute on Drug Abuse, operating under the National Institutes of Health within the Department of Health and Human Services, awarded a definitive cost-reimbursement contract valued at approximately $5.4 million to Medstar Health Research Institute Inc. on September 28, 2024. The contract, with an ultimate completion date of September 27, 2029, provides clinical support services for the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Branch research...

This is a firm-fixed price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI) to Medstar Health Research Institute Inc., a non-profit organization that provides clinical research and healthcare services to federal agencies. The contract is for Medstar to provide CEAC (Clinical Events Adjudication Committee) services to support Dr. Lederman's mitral cerclage Investigational Device Exemption (IDE) protocol, which will validate the protocol in a clinical outpatient...

This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Medstar Health Research Institute Inc. (doing business as Medstar Research Institute), a non-profit organization. The $103,272.00 contract is for the provision of medical residents to support clinical research at the NIAID Clinical Center in Rockville, Maryland. The award does not have a set-aside designation. Medstar Research Institute is an...

The National Institute of Allergy and Infectious Diseases awarded The Medical College of Wisconsin, Inc. a $3.28M definitive contract on July 1, 2023, to conduct research on the mitigation of multi-organ delayed effects of acute radiation exposure (DEARE) using the ACE-inhibitor lisinopril. The cost-no-fee contract, which extends through June 30, 2027, represents work performed in Wauwatosa, Wisconsin, and originated from a pre-solicitation notice issued in November 2021 seeking proposals for...

NASA awarded a $3.61 million grant to Icahn School of Medicine at Mount Sinai (ISMMS) on April 10, 2019, for research addressing cardiovascular disease risks and degenerative tissue effects from radiation exposure, with performance extending through December 31, 2026. The research directly supports gaps identified in NASA's Human Research Program (HRP) Integrated Research Plan, specifically targeting the development of tissue-specific experimental models for cardiovascular and other degenerative...